A randomised controlled pilot trial of oral 11ß-HSD1 inhibitor AZD4017 for wound healing in adults with type 2 diabetes mellitus (2021)

First Author: Ajjan R

Attributed to: MICA: Treatment According to Response in Giant cEll arTeritis (TARGET) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.03.23.21254200

Publication URI: http://dx.doi.org/10.1101/2021.03.23.21254200

Type: Preprint